| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Acid ceramidase |
|---|
| Ligand | BDBM50511263 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_1844336 (CHEMBL4344763) |
|---|
| IC50 | 293±n/a nM |
|---|
| Citation |  Di Martino, S; Tardia, P; Cilibrasi, V; Caputo, S; Mazzonna, M; Russo, D; Penna, I; Realini, N; Margaroli, N; Migliore, M; Pizzirani, D; Ottonello, G; Bertozzi, SM; Armirotti, A; Nguyen, D; Sun, Y; Bongarzone, ER; Lansbury, P; Liu, M; Skerlj, R; Scarpelli, R Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors. J Med Chem63:3634-3664 (2020) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Acid ceramidase |
|---|
| Name: | Acid ceramidase |
|---|
| Synonyms: | ASAH | ASAH1 | ASAH1_HUMAN | Acid ceramidase | Acid ceramidase (AC) |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 44662.65 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | Q13510 |
|---|
| Residue: | 395 |
|---|
| Sequence: | MPGRSCVALVLLAAAVSCAVAQHAPPWTEDCRKSTYPPSGPTYRGAVPWYTINLDLPPYK
RWHELMLDKAPVLKVIVNSLKNMINTFVPSGKIMQVVDEKLPGLLGNFPGPFEEEMKGIA
AVTDIPLGEIISFNIFYELFTICTSIVAEDKKGHLIHGRNMDFGVFLGWNINNDTWVITE
QLKPLTVNLDFQRNNKTVFKASSFAGYVGMLTGFKPGLFSLTLNERFSINGGYLGILEWI
LGKKDVMWIGFLTRTVLENSTSYEEAKNLLTKTKILAPAYFILGGNQSGEGCVITRDRKE
SLDVYELDAKQGRWYVVQTNYDRWKHPFFLDDRRTPAKMCLNRTSQENISFETMYDVLST
KPVLNKLTVYTTLIDVTKGQFETYLRDCPDPCIGW
|
|
|
|---|
| BDBM50511263 |
|---|
| n/a |
|---|
| Name | BDBM50511263 |
|---|
| Synonyms: | CHEMBL4448689 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C19H23N3O4 |
|---|
| Mol. Mass. | 357.4036 |
|---|
| SMILES | CC(=O)N1CCc2oc(=O)n(C(=O)NCCCCc3ccccc3)c2C1 |
|---|
| Structure | 
|
|---|
Search and Browse
